Il y a eu 50 transactions d'initiés récentes enregistrées pour Royalty Pharma plc (RPRX), dont 16 achats et 29 ventes. Le total des achats d'initiés s'élève à $112.4K et le total des ventes d'initiés à $20.79M.
Les initiés notables ayant une activité récente comprennent Coyne Terrance P., Bassler Bonnie L, Legorreta Pablo G.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — RPRX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-01 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
32,916 |
$48.33 |
$1.59M |
32,916 |
| 2026-03-31 |
Bassler Bonnie L |
Director |
Attribution de RSU |
815 |
$45.98 |
$37.47K |
73,947 |
| 2026-03-23 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
1,875 |
$45.53 |
$85.37K |
43,886 |
| 2026-03-02 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
583 |
$47.01 |
$27.41K |
45,761 |
| 2026-02-23 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
1,875 |
$45.32 |
$84.97K |
47,636 |
| 2026-02-11 |
Legorreta Pablo G. |
CEO, Chairman of the Board |
Attribution de RSU |
157,828 |
- |
- |
1,098,783 |
| 2026-02-11 |
Hite Christopher |
EVP & Vice Chairman |
Attribution de RSU |
26,626 |
- |
- |
685,136 |
| 2026-02-11 |
Coyne Terrance P. |
EVP & CFO |
Attribution de RSU |
26,626 |
- |
- |
49,511 |
| 2026-02-11 |
Urist Marshall |
EVP, Research & Investments |
Attribution de RSU |
19,970 |
- |
- |
27,368 |
| 2026-02-04 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
1,087 |
$43.29 |
$47.06K |
22,885 |
| 2026-02-03 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
6,195 |
$42.84 |
$265.41K |
23,972 |
| 2026-02-02 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
5,843 |
$42.08 |
$245.9K |
30,167 |
| 2026-01-30 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$41.09 |
$821.81K |
- |
| 2026-01-23 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$40.26 |
$805.11K |
20,000 |
| 2026-01-20 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
3,750 |
$39.35 |
$147.56K |
36,010 |
| 2026-01-16 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$39.52 |
$790.35K |
40,000 |
| 2026-01-09 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$40.78 |
$815.63K |
60,000 |
| 2026-01-02 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
3,750 |
$38.42 |
$144.06K |
39,760 |
| 2026-01-02 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$38.48 |
$769.65K |
80,000 |
| 2026-01-01 |
Mcgivern Arthur Richard |
EVP, Investments & Gc |
Inconnu |
706,393 |
- |
- |
- |
| 2025-12-31 |
Bassler Bonnie L |
Director |
Attribution de RSU |
967 |
$38.74 |
$37.46K |
73,132 |
| 2025-12-26 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$39.32 |
$786.38K |
100,000 |
| 2025-12-19 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$38.38 |
$767.58K |
120,000 |
| 2025-12-18 |
Lloyd George W. |
EVP, Investments & CLO |
Vente Informative |
30,654 |
$38.50 |
$1.18M |
- |
| 2025-12-17 |
Lloyd George W. |
EVP, Investments & CLO |
Vente Informative |
79,346 |
$38.57 |
$3.06M |
30,654 |
| 2025-12-16 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$38.32 |
$766.42K |
140,000 |
| 2025-12-15 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
3,750 |
$38.36 |
$143.85K |
43,510 |
| 2025-12-05 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
18,242 |
$39.15 |
$714.22K |
7,398 |
| 2025-12-03 |
Lloyd George W. |
EVP, Investments & CLO |
Vente Informative |
110,000 |
$39.77 |
$4.38M |
110,000 |
| 2025-12-01 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
3,750 |
$39.87 |
$149.5K |
47,260 |
| 2025-12-01 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
18,242 |
$39.90 |
$727.86K |
25,640 |
| 2025-11-24 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
624 |
$37.96 |
$23.69K |
51,010 |
| 2025-11-19 |
Lloyd George W. |
EVP, Investments & CLO |
Vente Informative |
2,470 |
$39.01 |
$96.35K |
- |
| 2025-11-17 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
3,750 |
$39.30 |
$147.39K |
54,760 |
| 2025-11-07 |
Urist Marshall |
EVP, Research & Investments |
Conversion (Achat) |
160,000 |
- |
- |
206,667 |
| 2025-11-05 |
Legorreta Pablo G. |
CEO, Chairman of the Board |
Attribution de RSU |
36,559 |
- |
- |
940,955 |
| 2025-11-05 |
Hite Christopher |
EVP & Vice Chairman |
Attribution de RSU |
6,168 |
- |
- |
658,510 |
| 2025-11-05 |
Coyne Terrance P. |
EVP & CFO |
Attribution de RSU |
6,168 |
- |
- |
58,510 |
| 2025-11-05 |
Lloyd George W. |
EVP, Investments & CLO |
Attribution de RSU |
6,168 |
- |
- |
58,510 |
| 2025-11-05 |
Urist Marshall |
EVP, Research & Investments |
Attribution de RSU |
4,626 |
- |
- |
43,882 |
| 2025-09-30 |
Bassler Bonnie L |
Director |
Attribution de RSU |
1,047 |
$35.79 |
$37.47K |
72,165 |
| 2025-08-11 |
Norden Gregory |
Director |
Vente Informative |
33,500 |
$36.23 |
$1.21M |
194,848 |
| 2025-08-08 |
Legorreta Pablo G. |
CEO, Chairman of the Board |
Don (Donné) |
60,000 |
- |
- |
692,701 |
| 2025-08-08 |
Coyne Terrance P. |
EVP & CFO |
Don (Donné) |
1,000 |
- |
- |
43,350 |
| 2025-08-08 |
Lloyd George W. |
EVP, Investments & CLO |
Don (Donné) |
8,500 |
- |
- |
- |
| 2025-08-08 |
Urist Marshall |
EVP, Research & Investments |
Don (Donné) |
3,000 |
- |
- |
263,412 |
| 2025-08-08 |
Norden Gregory |
Director |
Conversion (Vente) |
14,466 |
- |
- |
- |
| 2025-08-06 |
Legorreta Pablo G. |
CEO, Chairman of the Board |
Attribution de RSU |
21,901 |
- |
- |
904,396 |
| 2025-08-06 |
Hite Christopher |
EVP & Vice Chairman |
Attribution de RSU |
3,696 |
- |
- |
652,342 |
| 2025-08-06 |
Coyne Terrance P. |
EVP & CFO |
Attribution de RSU |
3,696 |
- |
- |
52,342 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
